Severe Erosive Pill Esophagitis Induced by Crizotinib Therapy: A Case Report and Literature Review

Previous case reports have described esophagitis thought to be secondary to crizotinib, an oral tyrosine-kinase inhibitor used in the treatment of anaplastic lymphoma kinase- (ALK-) positive non-small cell lung cancer (NSCLC). In those reports, the interval development of esophagitis was between two...

Full description

Saved in:
Bibliographic Details
Published in:Case Rep Gastrointest Med
Main Authors: Jung, Patrick, Fortinsky, Kyle J., Gallinger, Zane R., Tartaro, Piero
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2016
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5178341/
https://ncbi.nlm.nih.gov/pubmed/28053793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/3562820
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items